CN102725304B - 用于亲和色谱法的冲洗溶液和方法 - Google Patents

用于亲和色谱法的冲洗溶液和方法 Download PDF

Info

Publication number
CN102725304B
CN102725304B CN201080057457.6A CN201080057457A CN102725304B CN 102725304 B CN102725304 B CN 102725304B CN 201080057457 A CN201080057457 A CN 201080057457A CN 102725304 B CN102725304 B CN 102725304B
Authority
CN
China
Prior art keywords
protein
arginine
column
matrix
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201080057457.6A
Other languages
English (en)
Chinese (zh)
Other versions
CN102725304A (zh
Inventor
A·弗劳恩舒
K·比尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43598315&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN102725304(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG filed Critical Novartis AG
Publication of CN102725304A publication Critical patent/CN102725304A/zh
Application granted granted Critical
Publication of CN102725304B publication Critical patent/CN102725304B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CN201080057457.6A 2009-12-18 2010-12-17 用于亲和色谱法的冲洗溶液和方法 Active CN102725304B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28805909P 2009-12-18 2009-12-18
US61/288,059 2009-12-18
PCT/EP2010/070076 WO2011073389A1 (en) 2009-12-18 2010-12-17 Wash solution and method for affinity chromatography

Publications (2)

Publication Number Publication Date
CN102725304A CN102725304A (zh) 2012-10-10
CN102725304B true CN102725304B (zh) 2015-12-09

Family

ID=43598315

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201080057457.6A Active CN102725304B (zh) 2009-12-18 2010-12-17 用于亲和色谱法的冲洗溶液和方法

Country Status (18)

Country Link
US (3) US9505803B2 (https=)
EP (2) EP2513134B1 (https=)
JP (2) JP5909450B2 (https=)
KR (1) KR101858266B1 (https=)
CN (1) CN102725304B (https=)
AU (1) AU2010332778B2 (https=)
BR (1) BR112012014937B1 (https=)
CA (1) CA2784278C (https=)
DK (2) DK3272764T3 (https=)
ES (2) ES2982297T3 (https=)
IL (1) IL220164B (https=)
LT (2) LT2513134T (https=)
MX (1) MX2012007103A (https=)
PL (2) PL2513134T3 (https=)
PT (2) PT3272764T (https=)
RU (1) RU2564569C2 (https=)
SG (2) SG181771A1 (https=)
WO (1) WO2011073389A1 (https=)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007294731B2 (en) 2006-09-13 2014-04-17 Abbvie Inc. Cell culture improvements
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
NZ592095A (en) 2008-10-20 2013-01-25 Abbott Lab Isolation and purification of il-12 and tnf-alpha antibodies using protein a affinity chromatography
BRPI0920572A8 (pt) 2008-10-20 2015-10-27 Abbott Lab Inativação viral durante a purificação dos anticorpos
ES2982297T3 (es) * 2009-12-18 2024-10-15 Novartis Ag Método de cromatografía de afinidad
SG182553A1 (en) 2010-01-22 2012-08-30 Boehringer Ingelheim Int Chromatographic method for purifying fc-containing proteins
EP2714714B1 (en) 2011-06-01 2018-06-20 Novartis AG Wash solution and method for affinity chromatography
RU2654567C2 (ru) 2011-10-11 2018-05-21 Дженентек, Инк. Улучшенная сборка биспецифических антител
EP2997036B1 (en) 2013-05-15 2021-03-03 Medimmune Limited Purification of recombinantly produced polypeptides
US20150093800A1 (en) * 2013-09-05 2015-04-02 Genentech, Inc. Method for chromatography reuse
US9546208B2 (en) 2014-01-03 2017-01-17 Bio-Rad Laboratories, Inc. Removal of impurities from protein A eluates
US11566082B2 (en) 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
WO2016149088A1 (en) 2015-03-13 2016-09-22 Bristol-Myers Squibb Company Use of alkaline washes during chromatography to remove impurities
EP3337818B1 (en) * 2015-08-21 2026-03-18 F. Hoffmann-La Roche AG Affinity chromatography purification with low conductivity wash buffer
SI3337812T1 (sl) 2015-08-21 2021-08-31 F. Hoffmann-La Roche Ag Postopek za zmanjševanje beljakovin gostiteljske celice v afinitetni kromatografiji
US10654887B2 (en) 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
WO2017194592A1 (en) 2016-05-11 2017-11-16 Ge Healthcare Bioprocess R&D Ab Method of storing a separation matrix
WO2017194593A1 (en) 2016-05-11 2017-11-16 Ge Healthcare Bioprocess R&D Ab Method of cleaning and/or sanitizing a separation matrix
US10513537B2 (en) 2016-05-11 2019-12-24 Ge Healthcare Bioprocess R&D Ab Separation matrix
JP7031934B2 (ja) 2016-05-11 2022-03-08 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 分離マトリックス
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
US10889615B2 (en) 2016-05-11 2021-01-12 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
CA3031028C (en) * 2016-07-25 2024-02-13 Lu Wang Affinity chromatography wash buffer
US12448411B2 (en) 2016-09-30 2025-10-21 Cytiva Bioprocess R&D Ab Separation method
EP3668985B1 (en) 2017-08-17 2021-06-16 Just-Evotec Biologics, Inc. Method of purifying glycosylated protein from host cell galectins and other contaminants
CN107793469B (zh) * 2017-10-16 2021-07-30 上海药明生物技术有限公司 一种去除宿主细胞蛋白含量的亲和纯化工艺
KR102753090B1 (ko) * 2017-12-21 2025-01-14 젠자임 코포레이션 단백질 a 크로마토그래피 동안 불순물의 향상된 제거를 위한 방법
WO2019183334A1 (en) 2018-03-21 2019-09-26 Waters Technologies Corporation Non-antibody high-affinity-based sample preparation, sorbents, devices and methods
JP7840636B2 (ja) 2018-04-02 2026-04-06 アムジェン インコーポレイテッド エレヌマブ組成物及びその使用
WO2019217570A1 (en) * 2018-05-08 2019-11-14 Waters Technologies Corporation Methods, compositions and kits useful for ph gradient cation exchange chromatography
US12103949B2 (en) * 2018-08-14 2024-10-01 Bristol-Myers Squibb Company Protein recovery
CN114502569A (zh) * 2019-10-08 2022-05-13 北卡罗莱纳州立大学 免疫球蛋白纯化肽及其用途
WO2021191684A1 (en) * 2020-03-27 2021-09-30 Haemalogix Pty Ltd Composition and method
WO2021222120A1 (en) * 2020-04-27 2021-11-04 Alexion Pharmaceuticals, Inc. Protein a chromatography purification of an antibody
CN112827217A (zh) * 2020-12-29 2021-05-25 苏州良辰生物医药科技有限公司 一种层析柱清洗液及其应用
GEAP202516778A (en) * 2022-12-12 2025-06-25 H Lundbeck As Arginine wash in protein purification
WO2024233992A2 (en) * 2023-05-11 2024-11-14 Trophogen, Inc. Methods of manufacturing highly glycosylated glycoprotein hormones and their analogs
EP4729534A1 (en) 2024-10-21 2026-04-22 Technische Universität München, in Vertretung des Freistaats Bayern Polypeptides comprising protein domains linked via rigid amino acid linkers

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1680426A (zh) * 2004-01-21 2005-10-12 味之素株式会社 防止抗体变性的精制方法
CN101511859A (zh) * 2006-06-02 2009-08-19 惠氏公司 TGF-β超家族的蛋白质和肽用于纯化和治疗方法的用途
CN101511387A (zh) * 2006-09-08 2009-08-19 惠氏公司 使用亲和色谱法纯化蛋白质的精氨酸洗涤液

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704366A (en) 1984-06-22 1987-11-03 Bio-Rad Laboratories, Inc. Process for binding IgG to protein A
US4857320A (en) * 1987-02-19 1989-08-15 Monsanto Company Method of enhancing the solubility of tissue plasminogen activator
JPH01238534A (ja) * 1988-03-17 1989-09-22 Mitsui Toatsu Chem Inc エンドトキシンの除去方法
US5429746A (en) 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
DE69738075T2 (de) 1996-11-27 2008-05-21 Genentech, Inc., South San Francisco Affinitätsreinigung von polypeptiden an einer protein a-matrix
NZ507557A (en) 1998-05-06 2003-10-31 Genentech Inc Protein purification by ion exchange chromatography
EP1500661A1 (en) 1998-06-01 2005-01-26 Genetech, Inc. Separation of protein monomers from aggregates by use of ion-exchange chromatography
WO2002072615A1 (en) 2001-03-09 2002-09-19 Chugai Seiyaku Kabushiki Kaisha Method of purifying protein
ES2321539T3 (es) 2001-06-05 2009-06-08 Genetics Institute, Llc Procedimientos relativos a la purificacion de proteinas altamente anionicas.
CA2473144C (en) 2002-02-05 2013-05-28 Genentech, Inc. Protein purification
EP3225625A1 (en) 2002-09-11 2017-10-04 Chugai Seiyaku Kabushiki Kaisha Protein purification method
KR20050083827A (ko) * 2002-10-24 2005-08-26 이노스 파마슈티칼스, 인코포레이티드 서방성 ｌ-아르기닌 포뮬레이션 및 이의 제조방법 및 용도
JP4741242B2 (ja) * 2002-11-26 2011-08-03 アボット バイオセラピューティクス コーポレイション 新脈管形成を調節するα５β１インテグリンへのキメラ及びヒト化抗体
DE602004019761D1 (de) * 2003-01-08 2009-04-16 Novartis Vaccines & Diagnostic Stabilisierte wässrige zusammensetzungen mit gewebefaktorinhibitor (tfpi) oder gewebefaktorinhibitor-variante
GB0304576D0 (en) 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
CA2516518A1 (en) 2003-02-28 2004-09-10 Lonza Biologics Plc. Antibody purification by protein a and ion exchange chromatography
KR101221862B1 (ko) 2003-10-27 2013-01-14 와이어쓰 엘엘씨 하이드록시아파타이트 크로마토그래피를 사용한 고분자량응집체의 제거
DE602006003108D1 (de) 2005-03-03 2008-11-27 Ajinomoto Kk Methode zur Verbesserung der Ausbeute bei der Proteinreinigung mittels Gelfiltrationschromatographie und Arginin
EP1869065B1 (en) * 2005-03-11 2020-05-06 Wyeth LLC A method of weak partitioning chromatography
CN101365948B (zh) 2006-01-06 2012-11-07 Emd密理博公司 亲和层析基质及其制备和使用方法
WO2007109163A2 (en) 2006-03-16 2007-09-27 Amgen Inc Wash buffer and method of using
CA2645739A1 (en) 2006-03-20 2007-09-27 Medarex, Inc. Protein purification
US7754689B2 (en) 2006-06-02 2010-07-13 Wyeth Llc Finger-1 peptide analogs of the TGF-β superfamily
SI2061803T2 (sl) 2006-08-28 2023-01-31 Ares Trading S.A. Postopek za čiščenje proteinov, ki vsebujejo FC
AU2008206923A1 (en) 2007-01-17 2008-07-24 Merck Serono S.A. Process for the purification of Fc-containing proteins
CN101679509A (zh) 2007-06-01 2010-03-24 弗·哈夫曼-拉罗切有限公司 免疫球蛋白纯化
EP2281000A2 (en) 2008-05-15 2011-02-09 Novo Nordisk A/S Antibody purification process
SG2013061528A (en) 2008-08-14 2015-03-30 Merck Sharp & Dohme Methods for purifying antibodies using protein a affinity chromatography
ES2982297T3 (es) * 2009-12-18 2024-10-15 Novartis Ag Método de cromatografía de afinidad
EP2714714B1 (en) * 2011-06-01 2018-06-20 Novartis AG Wash solution and method for affinity chromatography

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1680426A (zh) * 2004-01-21 2005-10-12 味之素株式会社 防止抗体变性的精制方法
CN101511859A (zh) * 2006-06-02 2009-08-19 惠氏公司 TGF-β超家族的蛋白质和肽用于纯化和治疗方法的用途
CN101511387A (zh) * 2006-09-08 2009-08-19 惠氏公司 使用亲和色谱法纯化蛋白质的精氨酸洗涤液

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EVective elution of antibodies by arginine and arginine derivatives in aYnity column chromatography;Daisuke Ejima et al;《ANALYTICAL BIOCHEMISTRY》;20050626;第345卷(第2期);第250-257页 *
单克隆抗体纯化研究进展;应国清等;《中国医药工业杂志》;20091231;第39卷(第10期);第777-783页 *

Also Published As

Publication number Publication date
SG10201408384PA (en) 2015-01-29
US20190233469A1 (en) 2019-08-01
US9505803B2 (en) 2016-11-29
JP2016128495A (ja) 2016-07-14
EP2513134A1 (en) 2012-10-24
WO2011073389A1 (en) 2011-06-23
BR112012014937A2 (pt) 2016-03-08
PT3272764T (pt) 2024-04-24
ES2982297T3 (es) 2024-10-15
PL3272764T3 (pl) 2024-06-10
IL220164B (en) 2019-02-28
KR101858266B1 (ko) 2018-05-15
CA2784278A1 (en) 2011-06-23
US20170044211A1 (en) 2017-02-16
AU2010332778B2 (en) 2015-03-19
DK3272764T3 (da) 2024-05-06
PL2513134T3 (pl) 2018-02-28
EP2513134B1 (en) 2017-09-06
ES2651065T3 (es) 2018-01-24
JP5909450B2 (ja) 2016-04-26
DK2513134T3 (en) 2017-12-18
CN102725304A (zh) 2012-10-10
LT2513134T (lt) 2017-11-27
IL220164A0 (en) 2012-07-31
KR20120109506A (ko) 2012-10-08
RU2012130151A (ru) 2014-01-27
BR112012014937B1 (pt) 2021-01-19
RU2564569C2 (ru) 2015-10-10
LT3272764T (lt) 2024-05-10
EP3272764B1 (en) 2024-02-07
CA2784278C (en) 2019-02-26
SG181771A1 (en) 2012-07-30
US20120283416A1 (en) 2012-11-08
JP2013514073A (ja) 2013-04-25
EP3272764A1 (en) 2018-01-24
AU2010332778A1 (en) 2012-07-19
MX2012007103A (es) 2012-07-17
PT2513134T (pt) 2017-12-14

Similar Documents

Publication Publication Date Title
CN102725304B (zh) 用于亲和色谱法的冲洗溶液和方法
CN103596968B (zh) 用于亲和层析的洗涤溶液和方法
US20120149878A1 (en) Protein purification
JP6309005B2 (ja) アルブミンを精製するための方法
EP4380948A1 (en) Method to purify an antibody composition using cation exchange chromatography
CN114901671B (zh) 用于亲和层析的新的清洗缓冲溶液

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant